World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
129
Citations
60154
World Ranking
245
National Ranking
161

Medicine

D-Index
130
Citations
61378
World Ranking
2497
National Ranking
1408

John D. Reveille publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John D. Reveille sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 622 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

John D. Reveille D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John D. Reveille sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 129 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

John D. Reveille is affiliated with The University of Texas Health Science Center at Houston in the United States. Their research primarily focuses on medical and immunological fields, with significant contributions to rheumatology, immunology, hematology, pathology and forensic medicine, and molecular biology.

The main research topics covered by John D. Reveille's work include:

  • Spondyloarthritis Studies and Treatments
  • Rheumatoid Arthritis Research and Therapies
  • Psoriasis: Treatment and Pathogenesis
  • Autoimmune and Inflammatory Disorders Research
  • Systemic Lupus Erythematosus Research
  • Systemic Sclerosis and Related Diseases
  • Dermatology and Skin Diseases

The scientist has published extensively in several key venues, including:

  • Clinical Rheumatology
  • The Journal of Rheumatology
  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Arthritis Care & Research

Frequent coauthors collaborating with John D. Reveille include:

  • Michael H. Weisman
  • Lianne S. Gensler
  • Mark C. Hwang
  • Matthew A. Brown
  • Michael M. Ward

Among recently published papers, the following are notable:

  • "Ankylosing spondylitis risk factors: a systematic literature review," 2021, Clinical Rheumatology
  • "A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction," 2020, Nature Communications
  • "Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature," 2023, Annals of the Rheumatic Diseases
  • "Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis," 2021, Annals of the Rheumatic Diseases
  • "Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci," 2020, Investigative Ophthalmology & Visual Science

Their work has contributed to the understanding of autoimmune and inflammatory diseases, emphasizing conditions such as ankylosing spondylitis and related systemic disorders. The combination of clinical and molecular research approaches reflects an integration of pathology, immunology, and rheumatologic studies.

Best Publications

  • Human polymorphism at microRNAs and microRNA target sites.

    Liuqing Yang;Chunru Lin;Chunyu Jin;Joy C. Yang

  • Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.

    Unknown

  • 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

    Désirée van der Heijde;Sofia Ramiro;Robert Landewé;Xenofon Baraliakos

  • Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

    Paul R Burton;David G Clayton;Lon R Cardon;Nick Craddock

  • Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

    Désirée van der Heijde;Alan Kivitz;Michael H. Schiff;Joachim Sieper

  • Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    D M Evans;Spencer Cca.;J J Pointon;Z Su

  • A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus

    Vesela Gateva;Johanna K. Sandling;Geoff Hom;Kimberly E. Taylor

  • Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

    John D. Reveille;Anne Marie Sims;Patrick Danoy;David M. Evans

  • American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.

    Michael M. Ward;Atul Deodhar;Elie A. Akl;Andrew Lui

  • Guidelines for Clinical Use of the Antinuclear Antibody Test and Tests for Specific Autoantibodies to Nuclear Antigens

    Arthur Kavanaugh;Russell Tomar;John D Reveille;Daniel H. Solomon

  • Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

    Josef S. Smolen;Jürgen Braun;Maxime Dougados;Paul Emery

  • The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.

    Nigil Haroon;Robert D. Inman;Thomas J. Learch;Michael H. Weisman

  • Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

    Graciela S Alarcón;Gerald McGwin;Ana M Bertoli;Barri J Fessler

  • Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

    R. Landewé;J. Braun;A. Deodhar;M. Dougados

  • Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

    L. Van Bon;L. Van Bon;A. J. Affandi;A. J. Affandi;J. Broen;J. Broen;R. B. Christmann

  • Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII).

    L. B. Tucker;A. G. Uribe;M. Fernández;L. M. Vilá

  • Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual.

    Barri J. Fessler;Graciela S. Alarcón;Gerald McGwin;Jeffrey Roseman

  • Prognosis in systemic lupus erythematosus

    John D. Reveille;Alfred Bartolucci;Graciela S. Alarcón

  • Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: Support for the notion of a gene-dose effect from the X chromosome

    R. Hal Scofield;R. Hal Scofield;R. Hal Scofield;Gail R. Bruner;Bahram Namjou;Robert P. Kimberly

  • Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis

    H M Bastian;J M Roseman;G Mcgwin;G S Alarcón

  • Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    D.M. Evans;C.C.A. Spencer;J.J. Pointon;Z. Su

  • American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic

    Michael M. Ward;Atul Deodhar;Elie A. Akl;Andrew Lui

  • Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

    J. D. Reveille;A. M. Sims;P. Danoy;D. M. Evans

Frequent Co-Authors

Graciela S. Alarcón
Graciela S. Alarcón University of Alabama at Birmingham
Luis M. Vilá
Luis M. Vilá University of Puerto Rico, Medical Sciences Campus
Michael H. Weisman
Michael H. Weisman Cedars-Sinai Medical Center
Frank C. Arnett
Frank C. Arnett The University of Texas Health Science Center at Houston
Gerald McGwin
Gerald McGwin University of Alabama at Birmingham
John B. Harley
John B. Harley United States Department of Veterans Affairs
Kenneth M. Kaufman
Kenneth M. Kaufman Cincinnati Children's Hospital Medical Center
Judith A. James
Judith A. James Oklahoma Medical Research Foundation
Matthew A. Brown
Matthew A. Brown Guy's and St Thomas' NHS Foundation Trust
Marta E. Alarcón-Riquelme
Marta E. Alarcón-Riquelme University of Granada

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology as a field opens doors to various healthcare-related careers, particularly in nursing and advanced practice roles. Many students interested in expanding their qualifications pursue specialized nurse practitioner programs that complement their foundational knowledge in immunology.

For those seeking cost-effective options, the cheap psych np programs provide valuable pathways into mental health nursing, which often intersects with immune system research and patient care.

Nurse practitioners considering career advancement should be aware of salary trends. The dnp salary varies across states, influencing where graduates might choose to work after completing their immunology-related degrees or certifications.

Transitioning into specialized roles is common in this field. Nurses can enhance their qualifications through acute care nurse practitioner certification, which prepares them for handling more complex patient cases influenced by immune-related illnesses.

To fast-track careers, accelerated fnp programs offer a streamlined path for family nurse practitioners aiming to deepen their expertise in immunological health issues.

Best Scientists Citing John D. Reveille

Trending Scientists

Recently Published Articles